225 related articles for article (PubMed ID: 29235106)
1. WNT signalling: mechanisms and therapeutic opportunities.
Schulte G; Bryja V
Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
[TBL] [Abstract][Full Text] [Related]
2. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer.
Driehuis E; Clevers H
Br J Pharmacol; 2017 Dec; 174(24):4547-4563. PubMed ID: 28244067
[TBL] [Abstract][Full Text] [Related]
3. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.
Kagey MH; He X
Br J Pharmacol; 2017 Dec; 174(24):4637-4650. PubMed ID: 28574171
[TBL] [Abstract][Full Text] [Related]
4. Molecular regulation and pharmacological targeting of the β-catenin destruction complex.
van Kappel EC; Maurice MM
Br J Pharmacol; 2017 Dec; 174(24):4575-4588. PubMed ID: 28634996
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors.
Zimmerli D; Hausmann G; Cantù C; Basler K
Br J Pharmacol; 2017 Dec; 174(24):4600-4610. PubMed ID: 28521071
[TBL] [Abstract][Full Text] [Related]
6. Assembly and architecture of the Wnt/β-catenin signalosome at the membrane.
DeBruine ZJ; Xu HE; Melcher K
Br J Pharmacol; 2017 Dec; 174(24):4564-4574. PubMed ID: 28941231
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.
Lyou Y; Habowski AN; Chen GT; Waterman ML
Br J Pharmacol; 2017 Dec; 174(24):4589-4599. PubMed ID: 28752891
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.
Mariotti L; Pollock K; Guettler S
Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490
[TBL] [Abstract][Full Text] [Related]
9. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.
Flanagan DJ; Vincan E; Phesse TJ
Br J Pharmacol; 2017 Dec; 174(24):4666-4683. PubMed ID: 28568899
[TBL] [Abstract][Full Text] [Related]
10. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
11. New insights into cardiotoxicity caused by chemotherapeutic agents.
Grieve DJ; Davidson SM
Br J Pharmacol; 2017 Nov; 174(21):3675-3676. PubMed ID: 29046013
[TBL] [Abstract][Full Text] [Related]
12. Emerging areas of opioid pharmacology.
Kelly E; Henderson G; Bailey CP
Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
[TBL] [Abstract][Full Text] [Related]
13. Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.
Janovská P; Bryja V
Br J Pharmacol; 2017 Dec; 174(24):4701-4715. PubMed ID: 28703283
[TBL] [Abstract][Full Text] [Related]
14. The Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy.
Kikuchi A; Fumoto K; Kimura H
Br J Pharmacol; 2017 Dec; 174(24):4651-4665. PubMed ID: 28514532
[TBL] [Abstract][Full Text] [Related]
15. Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease.
Toledo EM; Gyllborg D; Arenas E
Br J Pharmacol; 2017 Dec; 174(24):4716-4724. PubMed ID: 28547771
[TBL] [Abstract][Full Text] [Related]
16. 'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.
Ong MS; Cai W; Yuan Y; Leong HC; Tan TZ; Mohammad A; You ML; Arfuso F; Goh BC; Warrier S; Sethi G; Tolwinski NS; Lobie PE; Yap CT; Hooi SC; Huang RY; Kumar AP
Br J Pharmacol; 2017 Dec; 174(24):4684-4700. PubMed ID: 28736855
[TBL] [Abstract][Full Text] [Related]
17. Molecular pharmacology of G protein-coupled receptors.
Summers RJ
Br J Pharmacol; 2016 Oct; 173(20):2931-3. PubMed ID: 27682321
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic acetylcholine receptors.
Wonnacott S; Bermudez I; Millar NS; Tzartos SJ
Br J Pharmacol; 2018 Jun; 175(11):1785-1788. PubMed ID: 29878346
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of cognition: a panacea for neuropsychiatric disease?
Bailey SJ; Neill JC; Moran PM
Br J Pharmacol; 2017 Oct; 174(19):3133-3135. PubMed ID: 28901012
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of oxidative stress: translational opportunities.
Daiber A; Di Lisa F; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1511-1513. PubMed ID: 28555779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]